Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
1998 1
1999 1
2000 6
2001 9
2002 5
2003 6
2004 9
2005 3
2006 5
2007 4
2008 4
2009 3
2010 5
2011 2
2013 1
2015 2
2016 6
2017 1
2019 4
2021 6
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Biochemistry of the non-mevalonate isoprenoid pathway.
Gräwert T, Groll M, Rohdich F, Bacher A, Eisenreich W. Gräwert T, et al. Among authors: rohdich f. Cell Mol Life Sci. 2011 Dec;68(23):3797-814. doi: 10.1007/s00018-011-0753-z. Epub 2011 Jul 9. Cell Mol Life Sci. 2011. PMID: 21744068 Review.
Biosynthesis of isoprenoids via the non-mevalonate pathway.
Eisenreich W, Bacher A, Arigoni D, Rohdich F. Eisenreich W, et al. Among authors: rohdich f. Cell Mol Life Sci. 2004 Jun;61(12):1401-26. doi: 10.1007/s00018-004-3381-z. Cell Mol Life Sci. 2004. PMID: 15197467 Review.
Deoxyxylulose phosphate pathway to terpenoids.
Eisenreich W, Rohdich F, Bacher A. Eisenreich W, et al. Among authors: rohdich f. Trends Plant Sci. 2001 Feb;6(2):78-84. doi: 10.1016/s1360-1385(00)01812-4. Trends Plant Sci. 2001. PMID: 11173292 Review.
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.
Friese-Hamim M, Ortiz Ruiz MJ, Bogatyrova O, Keil M, Rohdich F, Blume B, Leuthner B, Czauderna F, Hahn D, Jabs J, Jaehrling F, Heinrich T, Kellner R, Chan K, Tong AHY, Wienke D, Moffat J, Blaukat A, Zenke FT. Friese-Hamim M, et al. Among authors: rohdich f. Mol Cancer Ther. 2024 Feb 1;23(2):159-173. doi: 10.1158/1535-7163.MCT-23-0102. Mol Cancer Ther. 2024. PMID: 37940144 Free PMC article.
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors.
Menon M, Elliott R, Bowers L, Balan N, Rafiq R, Costa-Cabral S, Munkonge F, Trinidade I, Porter R, Campbell AD, Johnson ER, Esdar C, Buchstaller HP, Leuthner B, Rohdich F, Schneider R, Sansom O, Wienke D, Ashworth A, Lord CJ. Menon M, et al. Among authors: rohdich f. Sci Rep. 2019 Jan 17;9(1):201. doi: 10.1038/s41598-018-36447-4. Sci Rep. 2019. PMID: 30655555 Free PMC article.
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors.
Carducci MA, Wang D, Habermehl C, Bödding M, Rohdich F, Lignet F, Duecker K, Karpenko O, Pudelko L, Gimmi C, LoRusso P. Carducci MA, et al. Among authors: rohdich f. Cancer Res Commun. 2023 Aug 24;3(8):1638-1647. doi: 10.1158/2767-9764.CRC-23-0048. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37637935 Free PMC article. Clinical Trial.
83 results